| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 76.79 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : 0.63 |
EPS(TTM) : 14.86 |
|
Book Value(₹) : 230.32 |
Market Cap(₹Cr) : 15,832.15 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,821.74 | 1,697.75 | 1,528.28 | 1,340.37 | 1,215.73 |
| Other Income | 98.31 | 35.51 | 34.83 | 17.26 | 28.99 |
| Stock Adjustments | -64.49 | 43.54 | 13.15 | -8.50 | -2.49 |
| Total Income | 1,855.56 | 1,776.80 | 1,576.26 | 1,349.13 | 1,242.23 |
| EXPENDITURE : | |||||
| Raw Materials | 562.21 | 542.79 | 293.31 | 227.88 | 197.16 |
| Power and Fuel Cost | 3.50 | 4.10 | 4.46 | 4.41 | 4.01 |
| Other Manufacturing Expenses | 25.38 | 25.46 | 16.80 | 11.50 | 7.47 |
| Selling and Administration Expenses | 123.96 | 214.41 | 319.27 | 242.67 | 215.51 |
| Miscellaneous Expenses | 103.92 | 106.06 | 122.10 | 87.78 | 84.93 |
| Employee Benefit Expenses | 340.62 | 361.92 | 331.67 | 252.52 | 220.11 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 695.97 | 522.06 | 488.65 | 522.38 | 513.04 |
| Interest | 179.54 | 220.24 | 57.42 | 20.81 | 3.05 |
| Gross Profit | 516.43 | 301.82 | 431.23 | 501.57 | 509.99 |
| Depreciation | 154.38 | 181.77 | 102.39 | 64.66 | 51.46 |
| Profit Before Tax | 362.05 | 120.05 | 328.84 | 436.91 | 458.53 |
| Current Tax | 60.96 | 21.98 | 57.64 | 76.50 | 80.17 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 57.04 | 20.68 | -28.52 | -37.59 | -38.83 |
| Reported Net Profit | 244.05 | 77.39 | 299.72 | 398.01 | 417.19 |
| Extraordinary Items | -9.46 | 2.83 | 2.79 | 5.17 | -1.72 |
| Adjusted Net Profit | 253.51 | 74.56 | 296.93 | 392.84 | 418.91 |
| Adjustment below Net Profit | 0.69 | -2.84 | -2.76 | -0.15 | -1.01 |
| Profit/Loss Balance carried down | 2,461.66 | 2,487.17 | 2,190.21 | 1,892.28 | 1,557.74 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 100.06 | 0.00 | 99.93 | 81.65 |
| P & L Balance carried down | 2,706.40 | 2,461.66 | 2,487.17 | 2,190.21 | 1,892.28 |
| Dividend | 0.00 | 0.00 | 0.00 | 99.93 | 81.65 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 721.00 | 735.00 | 0.00 | 735.00 | 601.00 |
| Dividend Per Share(Rs) | 7.21 | 7.35 | 0.00 | 7.35 | 6.01 |
| Earnings Per Share-Unit Curr | 17.62 | 5.68 | 22.04 | 29.27 | 30.69 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 230.72 | 184.65 | 185.59 | 163.39 | 141.11 |
| Book Value(Adj)-Unit Curr | 230.72 | 184.65 | 185.59 | 163.39 | 141.11 |
